Profil bibliographique

Yuan Cao

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées

0Citations signalées

1Affiliations récentes

Les institutions déclarées

University of Science and Technology of China

Les domaines associés

Melanoma and MAPK PathwaysEndoplasmic Reticulum Stress and DiseaseNF-κB Signaling PathwaysProtein Degradation and InhibitorsProtein Kinase Regulation and GTPase Signaling

Les publications récentes

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 6 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 6: Comparative pathway analysis reveals distinct transcriptional effects of MTO and fulvestrant

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 1 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 1: MTO, unlike fulvestrant, maintains E2-mediated ER-SRC3 interaction

0 citations

Accès ouvert 2026 other OpenAlex

Data from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Abstract The estrogen receptor (ER or ERα) remains the primary therapeutic target for luminal breast cancer, with current treatments centered on competitive antagonists, receptor downregulators, and aromatase inhibitors. Despite these options, resistance frequently emerges, highlighting the need for alternative targeting strategies. We …

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 5 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 5: ER protein levels in wild-type and Y537S ER orthotopic xenograft tumors

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 2 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 2: MTO demonstrates enhanced growth inhibition in endocrine-resistant T47D cells

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 7 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 7: Comparative transcriptional pathway analysis of MTO and fulvestrant treatments

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 3 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 3: Three-dimensional spheroid growth in MCF7 cells expressing wildtype and mutant ER

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Table 1 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Table 1: Analysis of top computational docking candidates from the NIH Clinical Collection

0 citations

Accès ouvert 2026 supplementary-materials OpenAlex

Supplementary Fig. 4 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation

Han Wang, Yuxuan Luo, Sandeep Artham, Qianqian Wang et autres

Supplementary Fig. 4: Evaluation of combination treatment effects between MTO and established ER antagonists in MCF7 cells

0 citations

Accès ouvert 2026 erratum OpenAlex

Corrigendum to “Crosslinked porous three-dimensional cellulose nanofibers–gelatine biocomposite scaffolds for tissue regeneration” [Int. J. Biol. Macromol. 164 (2020) 1949–1959]

Ali Mirtaghavi, Andy Baldwin, Nader Tanideh, Moein Zarei et autres

gb, ir, pl, cn (code pays fourni par la source)

0 citations International Journal of Biological Macromolecules

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.